These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 5880731)
1. [Experience with the use of heparin in ambular prevention of coronary thrombosis under ambulatory conditions]. Aleĭnikova LI Kardiologiia; 1965; 5(4):50-2. PubMed ID: 5880731 [No Abstract] [Full Text] [Related]
3. [Prevention of experimental thrombosis of the coronary artery, in anesthetized dogs, with a low molecular weight heparin, enoxaparine (PK 10169)]. Uzan A; Clairefond P; Mardiguian J; Trillou M; Le Fur G; Mestre M Ann Pharm Fr; 1985; 43(6):539-46. PubMed ID: 3838029 [No Abstract] [Full Text] [Related]
5. [Heparin in the pathogenesis, prevention and therapy of ischemic heart disease]. Riecanský I; Kusá O; Luknárová O; Haviar V Vnitr Lek; 1983 May; 29(5):439-45. PubMed ID: 6880060 [No Abstract] [Full Text] [Related]
6. Left ventricular thrombosis and stroke following myocardial infarction. Lancet; 1990 Mar; 335(8692):759-60. PubMed ID: 1969513 [No Abstract] [Full Text] [Related]
7. [Changes of the thrombagglutination test in coronary disease after treatment with heparin]. Atanasov K; Iovkova T Kardiologiia; 1977 May; 17(5):142-3. PubMed ID: 886741 [No Abstract] [Full Text] [Related]
8. Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction. Turpie AG; Robinson JG; Doyle DJ; Mulji AS; Mishkel GJ; Sealey BJ; Cairns JA; Skingley L; Hirsh J; Gent M N Engl J Med; 1989 Feb; 320(6):352-7. PubMed ID: 2643772 [TBL] [Abstract][Full Text] [Related]
9. Experimental coronary artery spasm-induced thrombosis and myocardial infarction prevented by intravenous nifedipine. A study of hemodynamics, electrocardiograms, biochemistry and pathology. Jiang YQ; Na S; Ma FX; Shi HQ Chin Med J (Engl); 1988 Oct; 101(10):761-7. PubMed ID: 3150711 [No Abstract] [Full Text] [Related]
10. [Experience in preventive therapy of patients with chronic coronary insufficiency under polyclinic conditions]. Paranskaia ZhA Klin Med (Mosk); 1970 Apr; 48(4):109-12. PubMed ID: 5425704 [No Abstract] [Full Text] [Related]
11. A novel synthetic inhibitor of factor Xa decreases early reocclusion and improves 24-h patency after coronary fibrinolysis in dogs. Abendschein DR; Baum PK; Verhallen P; Eisenberg PR; Sullivan ME; Light DR J Pharmacol Exp Ther; 2001 Feb; 296(2):567-72. PubMed ID: 11160645 [TBL] [Abstract][Full Text] [Related]
12. Heparin and atherosclerosis. Engelberg H Monogr Atheroscler; 1978; (8):1-69. PubMed ID: 360049 [No Abstract] [Full Text] [Related]
13. A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. Helvetica Investigators. Serruys PW; Herrman JP; Simon R; Rutsch W; Bode C; Laarman GJ; van Dijk R; van den Bos AA; Umans VA; Fox KA N Engl J Med; 1995 Sep; 333(12):757-63. PubMed ID: 7643882 [TBL] [Abstract][Full Text] [Related]
14. Acute left main occlusion during percutaneous coronary intervention associated with heparin induced thrombocytopenia with thrombosis syndrome. Ziakas A; Gavrilidis S; Makris P; Louridas G J Interv Cardiol; 2005 Apr; 18(2):139-44. PubMed ID: 15882162 [TBL] [Abstract][Full Text] [Related]
15. [Prophylactic treatment of patients with chronic coronary insufficiency under ambulatory conditions]. Dolbilova VA Kardiologiia; 1967 Sep; 7(9):39-42. PubMed ID: 4181201 [No Abstract] [Full Text] [Related]